Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesLaboratory/PathologyProvidence Organic Acid Testing Coverage | OpenPay…
    Ask Trek AI about this page
    CurrentProvidence Health PlanPolicy 363

    Organic Acid Testing

    Customize your policy alerts

    Sign up for Providence Health Plan Policy 363 alerts

    Get alerted when Policy 363 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This Medicare-only policy governs medical necessity, coverage criteria, ordering, documentation, and billing of organic acid testing for Providence members. Testing is covered only when Medicare requirements and the policy's clinical and diagnosis-code criteria are met.

    Policy Summary
    PayerProvidence Health Plan
    PolicyOrganic Acid Testing
    Policy CodePolicy 363
    Change TypeAnnual review — no material changes
    Effective DateNov 1, 2026
    Last ReviewOct 1, 2026
    Next Review DateOct 1, 2027
    Key ActionDocument the specific medical problem, treating provider's order, clinical rationale, and how results will be used in direct management.
    SourceLink
    POLICY UPDATE CHANGES

    The policy revision history states that the annual review made no changes to the coverage criteria.

    Medicare OnlyProduct and benefit application
    3Primary CPT codes

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    E00-E89Eligible diagnosis range
    Claim reviewUnlisted-code pathway
    0Coverage changes

    Coverage Criteria

    Medically Necessary Organic Acid Testing

    Organic acid testing may be considered medically necessary for Medicare when ALL of the following are met:

    ALL of the following

    • The test is ordered by a provider who is treating the member for a specific medical problem.
    • The provider will promptly use the test results in the direct management of that specific medical problem.
    • The testing has established clinical utility and analytic validity.
    • The applicable Company medical policy criteria for organic acid testing are met.

    Not Medically Necessary

    Organic acid testing is considered not medically necessary when the applicable Medicare diagnostic-testing requirements or Company medical policy criteria are not met.

    ANY of the following

    • The test is not ordered by a provider who is treating the member for a specific medical problem.
    • The test results will not be promptly used in the direct management of that specific medical problem.
    • The testing lacks established clinical utility or analytic validity.
    • The applicable Company medical policy criteria are not met.

    Laboratory Panel Billing

    Laboratory panel services must be reported and submitted in accordance with Company coding requirements and applicable CPT and CMS guidelines.

    ALL of the following billing requirements apply

    • When no specific CPT or HCPCS code exists for a panel test, report the panel service using an unlisted code.
    • Do not report the individual tests in a panel separately as if they were performed individually; doing so misrepresents the services performed and is not appropriate under CPT or CMS guidelines.
    • Unbundling laboratory panels may be treated as fraudulent billing; CMS identified unbundling of lab panels as an example of fraudulent billing in a Healthcare Fraud Prevention Partnership white paper published in May 2018.
    • Unlisted codes are reviewed at the claim level for medical necessity, correct coding, and pricing.

    Coverage remains subject to Medicare and the member's Evidence of Coverage (EOC). Services or items that are excluded by Medicare or the member's benefit plan are not covered even if they may appear medically indicated for an individual, including services or procedures that are cosmetic, not medical in nature, or not medically reasonable or necessary under Title XVIII of the Social Security Act, §1862(a)(1)(A). If coverage is uncertain, review the member EOC or submit a pre-service organization determination request. The Medicare Advance Beneficiary Notice of Noncoverage (ABN) cannot be used for Medicare Advantage members.

    For adults, organic acid testing is considered not medically necessary without a supported indication for diagnosing a metabolic disorder or other applicable Company medical policy criteria. Clinical practice guidelines may support organic acid testing to diagnose metabolic disorders in adults; however, there is minimal information and limited clinical evidence regarding the validity and utility of testing in adults otherwise. Organic acid testing in newborns is considered standard of care.

    CPT codes 83918, 83919, and 83921 may be considered medically necessary when billed with a diagnosis code in the range of E00-E89 or any of the following diagnosis codes: K90.9, Z86.39, Z13.228, Z83.49, or G93.41. When diagnosis codes other than these are billed, CPT codes 83918, 83919, and 83921 will deny as not medically necessary. CPT 83921 for methylmalonic acid (MMA) testing may also be considered medically necessary for potential vitamin B12 deficiency when billed with D51.0, D51.1, D51.2, D51.3, D51.8, or D51.9.

    Covered Indications

    Evaluation of Metabolic Disorders

    CPT 83918, 83919, and 83921 may be medically necessary for evaluation of metabolic disorders when the ordering and diagnosis requirements are met.

    Medicare diagnostic-testing requirements

    • The test is ordered by a provider who is treating the member for a specific medical problem and who will promptly use the results in the direct management of that problem.
    • The testing has established clinical utility and analytic validity.

    Eligible diagnosis criteria

    • CPT 83918, 83919, or 83921 with an eligible diagnosis

      • The billed diagnosis is in the range E00-E89, or is K909, Z8639, Z13228, Z8349, or G9341.E00-E89; K909; Z8639; Z13228; Z8349; G9341

    Coding and Code Sets

    CPT codes for organic acid testingCPTCovered
    81599Unlisted multianalyte assay with algorithmic analysis
    83918Organic acids; total, quantitative, each specimen
    83919Organic acids; qualitative, each specimen
    83921Organic acid, single, quantitative
    HCPCSHCPCS
    No codes listed

    Provider and Billing Actions

    Prior Authorization

    Obtain prior authorization for unlisted codes

    For an unlisted code submitted for a potentially covered service addressed by this policy, prior authorization is recommended before the service to help avoid post-service denial.

    Prior Authorization

    Avoid post-service denial

    Prior authorization is recommended for an unlisted code submitted for a potentially covered service addressed by this policy. Obtaining authorization before the service may help avoid claim denial or delay after the service is performed.

    Documentation Required

    Document the clinical indication and intended use

    Background

    Organic acid testing evaluates urinary or other specimen metabolites and may be used in the evaluation of metabolic disorders. Medicare does not have specific national, local, or coverage-manual criteria for this service, so the policy supplements Medicare’s general diagnostic laboratory requirements with additional medical-necessity criteria. Testing in newborns is described as standard of care, while information on diagnostic validity and utility in adults is limited.

    Definitions

    Medicare diagnostic laboratory testing requirement
    Ordering providerA provider who is treating the member must order the diagnostic laboratory test.
    Specific medical problemThe test must address a specific medical problem for which the member is being treated.
    Use of resultsThe ordering provider must promptly use the test results in the direct management of that specific medical problem.
    Unlisted code
    When to useUse an unlisted code when no specific CPT or HCPCS code exists for the service.
    Review requiredUnlisted codes are reviewed at the claim level for medical necessity, correct coding, and pricing.

    Ordering Requirements

    Documentation Required

    Meet the ordering requirements

    The test must be ordered by a provider who is treating the member for a specific medical problem, and the ordering provider must promptly use the test results in the direct management of that problem.

    • Diagnostic testing must have established clinical utility and analytic validity.
    • Document the treating provider’s order and the specific medical problem being evaluated.

    Not Covered

    Organic acid testing is not covered when the Company medical-policy criteria are not met. This includes testing that does not satisfy the applicable Medicare diagnostic-testing requirements or supported clinical and diagnosis-code criteria.

    An unlisted-code service submitted for a non-covered service addressed by this policy is denied as not covered. Unlisted codes are reviewed at the claim level for medical necessity, correct coding, and pricing.

    Policy Summary
    PayerProvidence Health Plan
    PolicyOrganic Acid Testing
    Policy CodePolicy 363
    Change TypeAnnual review — no material changes
    Effective DateNov 1, 2026
    Last ReviewOct 1, 2026
    Next Review DateOct 1, 2027
    Key ActionDocument the specific medical problem, treating provider's order, clinical rationale, and how results will be used in direct management.
    SourceLink
    On This Page
    Coverage CriteriaCovered IndicationsCoding and Code SetsProvider and Billing ActionsBackgroundDefinitionsOrdering RequirementsNot Covered
    If an unlisted code is submitted for a non-covered service addressed in this policy, the claim will be denied as not covered.
  1. For an unlisted code submitted for a potentially covered service addressed in this policy, prior authorization is recommended to help avoid post-service denial.

    Review the Company non-covered and prior authorization lists for additional information.

  2. Code-list inclusion or omission does not imply or guarantee reimbursement or coverage. Services remain subject to provider contracts, member benefits, eligibility, and potential utilization audit.
  3. A Medicare payment amount in the MPFS or MPFSDB, or the issuance of a CPT or HCPCS code, does not establish that the service is covered or medically reasonable and necessary.
  4. CPT and HCPCS codes may be subject to CMS National Correct Coding Initiative procedure-to-procedure bundling edits and medically unlikely edits (MUEs); this policy does not take precedence over applicable NCCI edits or MUEs.
  5. Additional CPT 83921 criterion for potential vitamin B12 deficiency

    • CPT 83921 is used for methylmalonic acid testing for potential vitamin B12 deficiency and is billed with D51.0, D51.1, D51.2, D51.3, D51.8, or D51.9.D51.0, D51.1, D51.2, D51.3, D51.8, or D51.9

      This is an additional potential indication for CPT 83921.

  6. Newborn Evaluation for Metabolic Disorders

    Organic acid testing may be medically necessary for newborn evaluation of metabolic disorders.

    Newborn metabolic-disorder evaluation

    • The testing is performed as part of the evaluation of a newborn for a metabolic disorder.

      The policy describes organic acid testing in newborns as standard of care.

    Document the specific medical problem being evaluated, the treating provider’s order, the clinical rationale for testing, and how the results will be promptly used in the direct management of that problem.

    • Include relevant diagnoses, conditions, functional status, comorbidities, physician recommendations, and clinical notes when applicable.
    Billing Rule

    Report panels with an unlisted code

    When no specific CPT or HCPCS code exists for a laboratory panel, report the panel service using an unlisted code rather than reporting the panel tests separately as if they were performed individually.

    Denial Risk

    Use an eligible diagnosis code

    CPT 83918, 83919, and 83921 may be considered medically necessary when billed with a diagnosis code in E00-E89, K909, Z8639, Z13228, Z8349, or G9341. When other diagnosis codes are billed, these CPT codes will deny as not medically necessary.

    • For CPT 83921 methylmalonic acid testing, potential vitamin B12 deficiency may also be supported by D51.0, D51.1, D51.2, D51.3, D51.8, or D51.9.
    Denial Risk

    Meet the policy criteria

    Organic acid testing is considered not medically necessary when the Company medical policy criteria are not met.

    Denial Risk

    Do not unbundle laboratory panels

    When no specific CPT or HCPCS code exists for a laboratory panel, do not report the component tests separately as if they were performed individually. The policy identifies this unbundling as an inappropriate misrepresentation of services and notes that it may result in denial or fraud-related concerns.

    Denial Risk

    Non-covered unlisted services will be denied

    An unlisted code submitted for a non-covered service addressed by this policy will be denied as not covered.

    Denial Risk

    Confirm coverage before using an unlisted code

    Do not submit an unlisted code for a service that is not covered under this policy. Such a submission will be denied as not covered.

    Billing Rule

    Check NCCI and MUE edits

    Claims may be affected by National Correct Coding Initiative procedure-to-procedure bundling edits and CMS medically unlikely edits, including daily maximum edits. This policy does not take precedence over NCCI edits or MUEs.

    • Refer to CMS coding guidelines and applicable code combinations.
    Potentially covered service
    Prior authorization is recommended before service for an unlisted code submitted for a potentially covered service addressed by this policy, to help avoid post-service denial.